VANCOUVER, Washington, Nov. 21, 2023 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential ...
Dr. Sepehr Lalezari, a top bariatric and minimally invasive surgeon in Los Angeles, has been named to Los Angeles Magazine's Best of the Best Top Doctors list for 2024. His innovative techniques and ...
LOS ANGELES, June 17, 2026 /PRNewswire/ -- Dr. Sepehr Lalezari, MD, FACS, founder of Lalezari Surgical and a board-certified bariatric and minimally invasive surgeon, has been named to Los Angeles ...
The MarketWatch News Department was not involved in the creation of this content. Dr. Sepehr Lalezari of Lalezari Surgical has achieved significant milestones in robotic-assisted surgery, having ...
Jay Lalezari, CEO, CytoDyn, emphasizes how regulatory T cells play a crucial role in tumor progression by enabling cancers to evade immune detection. Jay Lalezari, CEO of CytoDyn, explains how the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results